2022 October Cancer Innovation Awards-Nodal Awards
August 1, 2022
Quynh-Thu Le, MD's proposal, “Neoadjuvant Pembrolizumab Cetuximab for Locally Advanced Betel Nut Induced Oral Cavity Cancer (NEO-CORAL) Phase II Clinical Trial”, was selected for funding as one of the Stanford Cancer Institute (SCI) 2022 October Cancer Innovation Awards-Nodal Awards.